|
cellubrevin-VAMP4-endobrevin-syntaxin-6 complex
|
GO_0070066 |
[A SNARE complex that contains cellubrevin (VAMP3), VAMP4, endobrevin (VAMP8), and syntaxin 6 (or orthologs thereof).] |
|
syntaxin-6-syntaxin-16-Vti1a complex
|
GO_0070067 |
[A SNARE complex that contains syntaxin 6, syntaxin 16, and Vti1a (or orthologs thereof).] |
|
VAMP4-syntaxin-6-syntaxin-16-Vti1a complex
|
GO_0070068 |
[A SNARE complex that contains VAMP4, syntaxin 6, syntaxin 16, and Vti1a (or orthologs thereof).] |
|
obsolete chromatin remodeling involved in meiosis I
|
GO_1905886 |
[OBSOLETE. Any chromatin remodeling that is involved in meiosis I.] |
|
autoinducer AI-2 transmembrane transport
|
GO_1905887 |
[The process in which (2R,4S)-2-methyltetrahydrofuran-2,3,3,4-tetrol (autoinducer AI-2) is transported across a membrane. AI-2 is produced by prokaryotes and is believed to play a role in quorum sensing.] |
|
negative regulation of triglyceride transport
|
GO_1905884 |
[Any process that stops, prevents or reduces the frequency, rate or extent of triglyceride transport.] |
|
regulation of triglyceride transport
|
GO_1905883 |
[Any process that modulates the frequency, rate or extent of triglyceride transport.] |
|
positive regulation of triglyceride transport
|
GO_1905885 |
[Any process that activates or increases the frequency, rate or extent of triglyceride transport.] |
|
negative regulation of cellular response to very-low-density lipoprotein particle stimulus
|
GO_1905888 |
[Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.] |
|
regulation of cellular response to very-low-density lipoprotein particle stimulus
|
GO_1905890 |
[Any process that modulates the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.] |
|
positive regulation of cellular response to very-low-density lipoprotein particle stimulus
|
GO_1905889 |
[Any process that activates or increases the frequency, rate or extent of cellular response to very-low-density lipoprotein particle stimulus.] |
|
obsolete positive regulation of cellular response to thapsigargin
|
GO_1905893 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of cellular response to thapsigargin.] |
|
obsolete regulation of cellular response to tunicamycin
|
GO_1905894 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of cellular response to tunicamycin.] |
|
obsolete regulation of cellular response to thapsigargin
|
GO_1905891 |
[OBSOLETE. Any process that modulates the frequency, rate or extent of cellular response to thapsigargin.] |
|
obsolete negative regulation of cellular response to thapsigargin
|
GO_1905892 |
[OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to thapsigargin.] |
|
obsolete negative regulation of cellular response to tunicamycin
|
GO_1905895 |
[OBSOLETE. Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to tunicamycin.] |
|
obsolete positive regulation of cellular response to tunicamycin
|
GO_1905896 |
[OBSOLETE. Any process that activates or increases the frequency, rate or extent of cellular response to tunicamycin.] |
|
regulation of smooth muscle tissue development
|
GO_1905899 |
[Any process that modulates the frequency, rate or extent of smooth muscle tissue development.] |
|
macromolecule deacylation
|
GO_0098732 |
[The removal of an acyl group, any group or radical of the form RCO- where R is an organic group, from a macromolecule.] |
|
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell
|
GO_0035602 |
[The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands, which stops, prevents, or reduces the frequency, rate or extent of the occurrence or rate of cell death by apoptotic process in the bone marrow.] |